Article Details
Retrieved on: 2025-02-20 21:40:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In January 2025:- BioNTech SE:- An open-label, controlled, multi-site, interventional, 2-arm, Phase II trial of BNT113 in combination with ...
Article found on: www.theglobeandmail.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here